Amedeo Smart

Free Medical Literature Service

 

Amedeo

Pancreatitis
  Free Subscription

Articles published in
PLoS One
    January 2026
  1. URBONAS K, Stachneviciute G, Jasukaitiene A, Ignatavicius P, et al
    Overexpression of EMT-related transcription factors SNAI1 and ZEB1 is associated with more aggressive clinicopathological features of pancreatic cancer.
    PLoS One. 2026;21:e0339964.
    >> Share

  2. YUAN Y, Luo Q, Yan F, Li L, et al
    Effectiveness and safety of nurse-led different epidural analgesia methods based on symptom management theory in patients with severe acute pancreatitis: A single-center RCT protocol.
    PLoS One. 2026;21:e0337803.
    >> Share

  3. TOMSOVSKA V, Leontovyc I, Zacharovova K, Fabryova E, et al
    Evaluation of rat pancreatic islets damage after siRNA microporation.
    PLoS One. 2026;21:e0340066.
    >> Share

  4. WEI X, Yan R, Wang S, Jiang Y, et al
    Multi-omics analysis and functional validation of CHEK1 as an independent prognostic biomarker in Pancreatic cancer.
    PLoS One. 2026;21:e0340878.
    >> Share

  5. MALVIK M, Kilk K, Muller R, Salupere R, et al
    Shifts in amino acids profile in chronic pancreatitis.
    PLoS One. 2026;21:e0341087.
    >> Share

  6. ZHU K, Hu H, Yang Z, Zhu Z, et al
    Integrated microbiomics and metabolomics analysis reveals distinct profiles in carbapenem-resistant Acinetobacter baumannii and Escherichia coli infections in Pancreatitis-associated sepsis.
    PLoS One. 2026;21:e0340895.
    >> Share

  7. JAZIEH K, Carlson EE, Siddiqui Z, Connelly KE, et al
    Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer.
    PLoS One. 2026;21:e0343022.
    >> Share

  8. LV Y, Yu F, Xiang B
    Long-term clinical outcomes of endoscopic retrograde cholangiopancreatography for pancreatic duct stone treatment in children with chronic pancreatitis.
    PLoS One. 2026;21:e0336638.
    >> Share

  9. ZHAO J, Peng Y, Xu C
    Predictive value of red cell distribution width to albumin ratio for acute kidney injury in patients with acute pancreatitis.
    PLoS One. 2026;21:e0341471.
    >> Share

  10. ZENGIN E, Ucgun A, Cevik ME, Evrimler S, et al
    The association between epicardial adipose tissue thickness and diabetes mellitus, hyperlipidemia, hepatosteatosis, pancreatic steatosis and pancreatitis.
    PLoS One. 2026;21:e0343831.
    >> Share

  11. XU J, Long J, Luo G, Deng M, et al
    Association of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) with 90-day mortality in acute pancreatitis: A MIMIC-IV database analysis.
    PLoS One. 2026;21:e0343716.
    >> Share

  12. LIU J, Li D, Huang J, Hu Y, et al
    CD99-targeted immunomagnetic negative selection: A novel strategy for high-purity pancreatic islet isolation in murine models.
    PLoS One. 2026;21:e0344446.
    >> Share

  13. TU KJ, Roy SK, Kingsbury TJ, Shukla HD, et al
    HIF1alpha mediates resistance to radiation and to KRAS inhibitors in pancreatic adenocarcinoma.
    PLoS One. 2026;21:e0341912.
    >> Share

  14. TOMIMARU Y, Akita H, Tamari K, Maeda S, et al
    Study protocol: A randomized controlled trial of chemoradiotherapy versus chemotherapy as neoadjuvant therapy for resectable pancreatic cancer (CSGO-HBP-027).
    PLoS One. 2026;21:e0345459.
    >> Share


  15. Retraction: Ph-triazole as a therapeutic agent for pancreatic cancer: Synthesis, in silico, and in vitro evaluation.
    PLoS One. 2026;21:e0345609.
    >> Share

  16. QIN Z, Li K, Li X, Wang H, et al
    CAPG serves as a prognostic biomarker and promotes proliferation and migration in pancreatic ductal adenocarcinoma.
    PLoS One. 2026;21:e0346011.
    >> Share

  17. SHEN X, Yao J, Wang Z, Chen R, et al
    Identification of autophagy-related key biomarkers in caerulein induced acute pancreatitis: In silico and in vivo study.
    PLoS One. 2026;21:e0344110.
    >> Share

  18. ZHU W, Zhao X, Hao W, Zhou X, et al
    Engineering exosomes with iRGD for targeted RNAi therapy against pancreatic cancer mediated by long non-coding RNA PLBD1-AS1.
    PLoS One. 2026;21:e0345697.
    >> Share

  19. WANG Y, Li J, Yu Z, Li S, et al
    A pyroptosis-related gene signature for the diagnosis of acute pancreatitis.
    PLoS One. 2026;21:e0347204.
    >> Share


  20. Retraction: GATA4 inhibits cell differentiation and proliferation in pancreatic cancer.
    PLoS One. 2026;21:e0348036.
    >> Share

  21. BRANDSTETTER J, Goldstein L, Schreiber T, Palme R, et al
    Targeting pancreatic cancer with combined inhibition of EGFR and RAF.
    PLoS One. 2026;21:e0347843.
    >> Share

  22. ZHU Y, Zhu L, Liu Y, Ji Y, et al
    Interpretable miRNA-based prediction model for early detection of pancreatic cancer: Development and cross-platform validation.
    PLoS One. 2026;21:e0348699.
    >> Share

  23. BOGNAR AS, Sukos DA, Patoni C, Szalai EA, et al
    One out of four patients with pancreatic cancer experience psychological symptoms: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0348435.
    >> Share

  24. CHEN L, Guo F, Hong C
    Identification of key genes and signaling pathways associated with acute pancreatitis and acute lung injury by bioinformatics analysis.
    PLoS One. 2026;21:e0350013.
    >> Share

  25. HUANG J, Ye H, Lin J, Luo D, et al
    Economic evaluation of the second-line regimen of liposome irinotecan (II) combined with 5-FU/LV versus placebo combined with 5-FU/LV for locally advanced or metastatic pancreatic ductal adenocarcinoma in China.
    PLoS One. 2026;21:e0351853.
    >> Share

  26. LIU J, Liu T, Yang L, Hu Y, et al
    Key molecular mechanisms of mitochondrial metabolic pathways in specific cell subpopulations of pancreatic cancer based on scRNA-seq and bulk RNA-seq.
    PLoS One. 2026;21:e0351701.
    >> Share

  27. MIYAKE F, Ishihara S, Ando N, Tange S, et al
    Compressive stress inhibits proliferation in AsPC-1 pancreatic cancer cells and reduction of Myc protein.
    PLoS One. 2026;21:e0352769.
    >> Share

  28. YAWATA E, Bamba Y, Kawai Y, Honda H, et al
    Clinical relevance of hyperamylasemia and pancreatitis-like imaging linked with accidental hypothermia.
    PLoS One. 2026;21:e0353128.
    >> Share

  29. AL-DAWOUDI A, Varlamov D, Dalain M, Kopytko N, et al
    Development and internal validation of an early inpatient risk score for in-hospital mortality in acute pancreatitis: A retrospective cohort study.
    PLoS One. 2026;21:e0352980.
    >> Share

  30. SHICHI Y, Tsumoto H, Fujiwara M, Nonaka K, et al
    Mucin expression in pancreatic ductal adenocarcinoma cell lines in 2D and 3D cultures: A proteomic and immunocytochemical analysis.
    PLoS One. 2026;21:e0353991.
    >> Share

    January 2025
  31. NADEEM A, Ashraf R, Mahmood T, Parveen S, et al
    Automated CAD system for early detection and classification of pancreatic cancer using deep learning model.
    PLoS One. 2025;20:e0307900.
    >> Share

  32. ABDO E, Ismail MA, Al Hadidi S, Al-Mrahleh M, et al
    Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells.
    PLoS One. 2025;20:e0311615.
    >> Share

  33. BHATTACHARJEE K, Ghosh A
    Identification of key regulators in pancreatic ductal adenocarcinoma using network theoretical approach.
    PLoS One. 2025;20:e0313738.
    >> Share

  34. XIAO X, Huang P, Xu XT
    The choice of adjuvant radiotherapy in pancreatic cancer patients after up-front radical surgery.
    PLoS One. 2025;20:e0317995.
    >> Share

  35. WU Q, Liao L, Deng Q
    Association between red blood cell distribution width-to-albumin ratio at admission and all-cause mortality in patients with acute pancreatitis based on the MIMIC-III database.
    PLoS One. 2025;20:e0318873.
    >> Share

  36. LIU XW, Zhang YH, Xu L, Xing JB, et al
    Exploring the effects of quercetin-added pancreatic diet on metabolic homeostasis in dogs via metabolomics.
    PLoS One. 2025;20:e0318159.
    >> Share

  37. ZHANG Y, Ma H, Wang R, Li L, et al
    Correlation between baseline anion gap and early acute kidney injury in patients with acute pancreatitis in the intensive care unit: A single-center retrospective cohort study.
    PLoS One. 2025;20:e0315386.
    >> Share

  38. DING C, Yang JF, Wang X, Zhou YF, et al
    Diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration-based cytology for distinguishing malignant and benign pancreatic cystic lesions: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314825.
    >> Share

  39. HUANG ZH, Zhang J, Xu XY, Wang Y, et al
    Hypnotic drug use and intraoperative fluid balance associated with postoperative delirium following pancreatic surgery: A retrospective, observational, single-center study.
    PLoS One. 2025;20:e0319380.
    >> Share

  40. LIAO J, Lu D, Xie H, Wang M, et al
    The role of TyG index as a predictor of all-cause mortality in hospitalized patients with acute pancreatitis: a retrospective study utilizing the MIMIC-IV database.
    PLoS One. 2025;20:e0308994.
    >> Share

  41. XIA T, Li J, Liu Z, Jiao X, et al
    Impact of surgical approaches on long-term survival outcomes of patients with pancreatic neuroendocrine carcinoma.
    PLoS One. 2025;20:e0319906.
    >> Share

  42. SOLEIMANI Y, Nayebi M, Mahmoudi S, Daraei M, et al
    Cadmium exposure and risk of pancreatic cancer: Systematic review and meta-analysis.
    PLoS One. 2025;20:e0319283.
    >> Share

  43. LE KDR, Patel H, Downie E
    A systematic review on the prognostic role of radiologically-proven sarcopenia on the clinical outcomes of patients with acute pancreatitis.
    PLoS One. 2025;20:e0322409.
    >> Share

  44. KHANI M, Assadi Shalmani M, Taleban A, Tsai S, et al
    The impact of socioeconomic factors on pancreatic cancer care utilization.
    PLoS One. 2025;20:e0320518.
    >> Share

  45. GE H, Wolters-Eisfeld G, Hackert T, Li Y, et al
    Development of a hypoxia-responsive macrophage prognostic model using single-cell and bulk RNA sequencing in pancreatic cancer.
    PLoS One. 2025;20:e0322618.
    >> Share

  46. GONZALO-ENCABO P, Gardiner J, Norris MK, Wilson RL, et al
    Resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing neoadjuvant chemotherapy: Study protocol for the REBUILD trial.
    PLoS One. 2025;20:e0322192.
    >> Share

  47. LI W, Li N, Zhan Y, Gu J, et al
    Blood urea nitrogen to albumin ratio as predictor of mortality among acute pancreatitis patients in ICU: A retrospective cohort study.
    PLoS One. 2025;20:e0323321.
    >> Share

  48. DENG Q, Yang K, Liao Q, Tang X, et al
    Comprehensive analysis and experiment validation of five cuproptosis-related genes in prognosis, immune infiltration and metabolic characterization of pancreatic cancer.
    PLoS One. 2025;20:e0323458.
    >> Share

  49. YANG X, Zhang M, Lv L, Chen X, et al
    Total bilirubin-to-albumin ratio and short- and long-term all-cause mortality in acute pancreatitis: Evidence from the MIMIC-IV database.
    PLoS One. 2025;20:e0323330.
    >> Share

  50. PETERS LM, Reding Graf T, Graf R, Mevissen M, et al
    Regenerating island-derived protein 3E concentrations in healthy dogs and dogs with various inflammatory processes.
    PLoS One. 2025;20:e0324090.
    >> Share

  51. ISHIKAWA-KAKIYA Y, Maruyama H, Tanoue K, Higashimori A, et al
    Evaluation of the 22G Franseen needle and 22G Lancet needle for endoscopic ultrasonography-guided tissue acquisition sampling in solid pancreatic lesions: Propensity score weighting.
    PLoS One. 2025;20:e0322857.
    >> Share

  52. ZHENG Z, Lu Z, Yan F, Song Y, et al
    The role of novel biomarkers in the early diagnosis of pancreatic cancer: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0322720.
    >> Share

  53. KIMURA N, Shirai Y, Itoh A, Hirano K, et al
    A multicenter prospective study to determine the optimal range of lymph node dissection in pancreatic cancer surgery after neoadjuvant chemotherapy (LYMRIN-Trial): Project study by the Japan Pancreas Society and JON 2302-P.
    PLoS One. 2025;20:e0325667.
    >> Share

  54. NIEDRA H, Rogoza O, Saksis R, Peculis R, et al
    Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkers.
    PLoS One. 2025;20:e0325672.
    >> Share

  55. SALGADO-GARZA G, Willy A, Rocha FG, Mayo SC, et al
    The VIPR-1 trial (Visualizing Ischemia in the Pancreatic Remnant): Assessing the role of intraoperative indocyanine green perfusion in predicting postoperative pancreatic leaks and fistulas: Protocol for a phase II clinical trial.
    PLoS One. 2025;20:e0311025.
    >> Share

  56. ZHAO H, Li R, Guo X, Kang J, et al
    Mechanism of Plantamajoside in inhibiting ferroptosis of pancreatic beta cells and treatment of T2DM via activation of the xCT/GPX4 pathway.
    PLoS One. 2025;20:e0325674.
    >> Share

  57. ZHAN Z, Zheng X, Xu S, Zheng H, et al
    Rising burden of pancreatic cancer in China: Trends, drivers, and future projections.
    PLoS One. 2025;20:e0327009.
    >> Share

  58. SUZUKI Y, Sugimori M, Kanemaru Y, Onodera S, et al
    Development of a novel PIK3CA-mutated pancreatic tumor mouse model and evaluation of the therapeutic effects of a PI3K inhibitor.
    PLoS One. 2025;20:e0326491.
    >> Share

  59. LI L, Zhang Y, Leng J, Li S, et al
    The global, regional and national burden of pancreatitis due to alcohol use: Results from the Global Burden of Disease Study 2021 and projections to 2040.
    PLoS One. 2025;20:e0327831.
    >> Share

  60. HEMPEL S, Kolbinger FR, Oehme F, Radulova-Mauersberger O, et al
    Pancreatoduodenectomy versus total pancreatectomy and simultaneous intraportal islet autotransplantation for periampullary cancer at high-risk of postoperative pancreatic fistula (XANDTX-trial): Protocol of a randomized controlled pilot trial.
    PLoS One. 2025;20:e0327949.
    >> Share

  61. ZHOU X, Jiang B, You N, Qian X, et al
    Association between albumin infusion and sepsis risk of patients with acute pancreatitis.
    PLoS One. 2025;20:e0314738.
    >> Share

  62. BIAN J, Wang X, Chen Y, Lu G, et al
    The association between Albumin-Corrected Anion Gap (ACAG) and the risk of acute kidney injury in patients with acute pancreatitis: A retrospective analysis based on the MIMIC-IV database.
    PLoS One. 2025;20:e0330458.
    >> Share

  63. YAN QY, Mo XM, Cai WW, Peng Y, et al
    Nucleated red blood cell count as a novel predictive biomarker for acute kidney injury and prognosis in patients with acute pancreatitis: A retrospective cohort study.
    PLoS One. 2025;20:e0330611.
    >> Share

  64. MAO Y, Liu Q, Fan H, He W, et al
    Risk prediction model for post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0332378.
    >> Share

  65. HUANG H, Huang Z, Chen M, Okamoto K, et al
    Correction: Evaluation of the therapeutic efficiency and efficacy of blood purification in the treatment of severe acute pancreatitis.
    PLoS One. 2025;20:e0332933.
    >> Share

  66. HOU Z, Hou S, Wang Z, Wang H, et al
    The influence of somatostatin analogues on the incidence of pancreatic fistulas and postoperative morbidity in patients undergoing pancreatic resection: A Bayesian network meta-analysis.
    PLoS One. 2025;20:e0331909.
    >> Share

  67. QIU H, Fu Y, Lv Z, Zhu X, et al
    Risk prediction of all-cause mortality in hospitalized patients with severe acute pancreatitis by serum urea nitrogen/albumin ratio.
    PLoS One. 2025;20:e0326543.
    >> Share

  68. MANEENET J, Awale S, Boonyarat C, Waiwut P, et al
    Anti-cancer activity of 7-methoxyheptaphylline from Clausena harmandiana against PANC-1 pancreatic cancer cells and its sustainable extraction method.
    PLoS One. 2025;20:e0334901.
    >> Share

  69. CAI X, Jiang X, Nan W, Peng Z, et al
    Blood urea nitrogen to serum albumin ratio predicts 28-day and 90-day mortality in patients with acute pancreatitis: A retrospective cohort study.
    PLoS One. 2025;20:e0335808.
    >> Share

  70. HASAN MS, Ni S, Kamal FB, Blossey MF, et al
    Sequestration and suppressed synthesis of oncogenic HMGA1 using engineered adenoviruses decreases human pancreatic and breast cancer cell characteristics.
    PLoS One. 2025;20:e0335934.
    >> Share

  71. JAHAN N, Siddiquee NH, Riva RAK, Chowdhury NU, et al
    Mechanistic insight into the antidiabetic effects of Ficus hispida fruits: Inhibition of intestinal glucose absorption and pancreatic beta-cell apoptosis.
    PLoS One. 2025;20:e0337465.
    >> Share

  72. HUANG K, Lan X, Chen Z, Xiao H, et al
    Global trends and future predictions of pancreatic cancer incidence and mortality from 1990 to 2030: A comparative analysis of China, Korea, Japan, and the USA.
    PLoS One. 2025;20:e0337181.
    >> Share

  73. ZHANG N, Li X, Li F, Jin J, et al
    Ph-triazole as a therapeutic agent for pancreatic cancer: Synthesis, in silico, and in vitro evaluation.
    PLoS One. 2025;20:e0334618.
    >> Share

    January 2024
  74. EVANS SM, Ivanova K, Cossio D, Pilgrim CHC, et al
    Registry-derived stage (RD-Stage) for capturing stage at diagnosis for pancreatic carcinoma in Australia.
    PLoS One. 2024;19:e0294443.
    >> Share

  75. SECHRIST ZR, Lee G, Schwarz EM, Cole CL, et al
    Validation of dual energy X-ray absorptiometry for longitudinal quantification of tumor burden in a murine model of pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0292196.
    >> Share

  76. HUANG H, Huang Z, Chen M, Okamoto K, et al
    Evaluation of the therapeutic efficiency and efficacy of blood purification in the treatment of severe acute pancreatitis.
    PLoS One. 2024;19:e0296641.
    >> Share

  77. KHRISTENKO E, Sinitsyn V, Rieden T, Girod P, et al
    CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
    PLoS One. 2024;19:e0291185.
    >> Share


  78. Retraction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer.
    PLoS One. 2024;19:e0298197.
    >> Share

  79. KORDSHOULI SO, Tahmasebi A, Moghadam A, Ramezani A, et al
    A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0289561.
    >> Share


  80. Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines.
    PLoS One. 2024;19:e0298557.
    >> Share

  81. TUSHOSKI-ALEMAN GW, Herremans KM, Underwood PW, Akki A, et al
    Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
    PLoS One. 2024;19:e0297325.
    >> Share

  82. DI CARLO P, Serra N, Fasciana TMA, Giammanco A, et al
    Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.
    PLoS One. 2024;19:e0294049.
    >> Share

  83. HUAN L, Yu F, Cao D, Zhou H, et al
    Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0295983.
    >> Share

  84. GRIFFIN JI, Chen X, Duan L, Mu Q, et al
    Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
    PLoS One. 2024;19:e0300723.
    >> Share

  85. LANG H, Lin N, Chen X, Xiang J, et al
    Repressing miR-23a promotes the transdifferentiation of pancreatic alpha cells to beta cells via negatively regulating the expression of SDF-1alpha.
    PLoS One. 2024;19:e0299821.
    >> Share

  86. ZHANG C, Lin F, Guo DF, Wang QL, et al
    Assessing the causal link between liver function and acute pancreatitis: A Mendelian randomisation study.
    PLoS One. 2024;19:e0300890.
    >> Share

  87. MEHRA T, Lupatsch JE, Kossler T, Dedes K, et al
    Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    PLoS One. 2024;19:e0301271.
    >> Share

  88. HAWKINS HJ, Yacob BW, Brown ME, Goldstein BR, et al
    Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL).
    PLoS One. 2024;19:e0298808.
    >> Share

  89. SASAKI Y, Inouchi T, Nakatsuka R, Inoue A, et al
    Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells.
    PLoS One. 2024;19:e0302130.
    >> Share

  90. SHEN X, Zhu X, Liu H, Yuan R, et al
    Leveraging genomic signatures of oral microbiome-associated antibiotic resistance genes for diagnosing pancreatic cancer.
    PLoS One. 2024;19:e0302361.
    >> Share

  91. DUTTA D, Ray P, De A, Ghosh A, et al
    pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.
    PLoS One. 2024;19:e0297749.
    >> Share

  92. ZHU J, Wu L, Wang Y, Fang M, et al
    Predictive value of the Ranson and BISAP scoring systems for the severity and prognosis of acute pancreatitis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0302046.
    >> Share

  93. KIM MC, Kim JH, Jeon SK, Kang HJ, et al
    CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms.
    PLoS One. 2024;19:e0298278.
    >> Share

  94. HUANG K, Yuan X, Zhao P, He Y, et al
    Effect of chemotherapy on prognosis in patients with primary pancreatic signet ring cell carcinoma: A large real-world study based on machine learning.
    PLoS One. 2024;19:e0302685.
    >> Share

  95. HAN X, Hu MN, Ji P, Liu YF, et al
    Construction and alidation of a severity prediction model for acute pancreatitis based on CT severity index: A retrospective case-control study.
    PLoS One. 2024;19:e0303684.
    >> Share

  96. AGUILAR DIAZ DE LEON JS, Thirumurty M, Ly N
    Surface plasmon resonance microscopy identifies glycan heterogeneity in pancreatic cancer cells that influences mucin-4 binding interactions.
    PLoS One. 2024;19:e0304154.
    >> Share

  97. KUPTAWACH K, Noitung S, Buakeaw A, Puthong S, et al
    Lemon basil seed-derived peptide: Hydrolysis, purification, and its role as a pancreatic lipase inhibitor that reduces adipogenesis by downregulating SREBP-1c and PPAR-gamma in 3T3-L1 adipocytes.
    PLoS One. 2024;19:e0301966.
    >> Share

  98. VENDITTELLI P, Bokhorst JM, Smeets EMM, Kryklyva V, et al
    Automatic quantification of tumor-stroma ratio as a prognostic marker for pancreatic cancer.
    PLoS One. 2024;19:e0301969.
    >> Share

  99. LIMIJADI EKS, Muniroh M, Prajoko YW, Tjandra KC, et al
    The role of germline BRCA1 & BRCA2 mutations in familial pancreatic cancer: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0299276.
    >> Share

  100. SAMARIO-ROMAN J, Velasco M, Larque C, Cardenas-Vazquez R, et al
    NGF effects promote the maturation of rat pancreatic beta cells by regulating GLUT2 levels and distribution, and glucokinase activity.
    PLoS One. 2024;19:e0303934.
    >> Share

  101. MIRZAMOHAMADI S, HajiAbbasi MN, Roshandel G, Alimadadi M, et al
    Incidence and risk factors of pancreatic cancer during 15 years follow-up in the Golestan Cohort Study in Iran.
    PLoS One. 2024;19:e0300736.
    >> Share

  102. JANTHONGKAW A, Klaophimai S, Khamphaya T, Yimthiang S, et al
    Correction: Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention.
    PLoS One. 2024;19:e0305988.
    >> Share

  103. UTSUMI M, Inagaki M, Kitada K, Tokunaga N, et al
    Combination of sarcopenia and systemic inflammation-based markers for predicting the prognosis of patients undergoing pancreaticoduodenectomy for pancreatic cancer.
    PLoS One. 2024;19:e0305844.
    >> Share

  104. CYSNEIROS MAPC, Cirqueira MB, Barbosa LF, Chaves de Oliveira E, et al
    Immune cells and checkpoints in pancreatic adenocarcinoma: Association with clinical and pathological characteristics.
    PLoS One. 2024;19:e0305648.
    >> Share

  105. ECKERS A, Hunsicker O, Spies C, Balzer F, et al
    In vivo effects of balanced, low molecular 6% and 10% hydroxyethyl starch compared with crystalloid volume replacement on the coagulation system in major pancreatic surgery-a sub-analysis of a prospective double-blinded, randomized controlled trial.
    PLoS One. 2024;19:e0303165.
    >> Share

  106. MASUM MHU, Wajed S, Hossain MI, Moumi NR, et al
    An mRNA vaccine for pancreatic cancer designed by applying in silico immunoinformatics and reverse vaccinology approaches.
    PLoS One. 2024;19:e0305413.
    >> Share

  107. USUI M, Uchida K, Hayasaki A, Kishiwada M, et al
    Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0307876.
    >> Share

  108. YANG XJ, Xu YF, Zhu Q
    SPOP expression is associated with tumor-infiltrating lymphocytes in pancreatic cancer.
    PLoS One. 2024;19:e0306994.
    >> Share

  109. RAMSEY ML, Heald B, Gokun Y, Baker J, et al
    Germline multigene panel testing in acute and chronic pancreatitis.
    PLoS One. 2024;19:e0307076.
    >> Share

  110. YUGE T, Murata Y, Noguchi D, Ito T, et al
    Peritoneal washing cytology status as a crucial prognostic determinant in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection following preoperative chemoradiotherapy.
    PLoS One. 2024;19:e0309834.
    >> Share

  111. FRENZEL K, Kayser Y, Hornemann A, Kastner B, et al
    Complementary techniques for the reliable characterisation of tissue samples: A case study on pancreatic tumours analysed by means of X-ray fluorescence analysis and IR spectroscopy.
    PLoS One. 2024;19:e0306795.
    >> Share

  112. TAKEDA Y, Yamada D, Kobayashi S, Sasaki K, et al
    MicroRNA-26a-5p is a reliable biomarker in the adjuvant setting for pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0310328.
    >> Share

  113. YOSHIMOTO M, Hayakawa T, Yamaguchi M, Kimura S, et al
    alphavbeta3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine.
    PLoS One. 2024;19:e0310984.
    >> Share

  114. HUANG X, Li H, Zhao L, Xu L, et al
    Prediabetes increases the risk of pancreatic cancer: A meta-analysis of longitudinal observational studies.
    PLoS One. 2024;19:e0311911.
    >> Share


  115. Retraction: Chinese Herbal Medicine Suppresses Invasion-Promoting Capacity of Cancer-Associated Fibroblasts in Pancreatic Cancer.
    PLoS One. 2024;19:e0313436.
    >> Share

  116. GONG G, Wu Y, Jiang Y, Cao Y, et al
    Integrated global and unique metabolic characteristics to reveal the intervention effect of Yiyi decoction on acute pancreatitis.
    PLoS One. 2024;19:e0310689.
    >> Share

  117. CHEN SY, Song XJ, Lu JT, Liang JX, et al
    Application of alkaline phosphatase-to-hemoglobin and lactate dehydrogenase-to-hemoglobin ratios as novel noninvasive indices for predicting severe acute pancreatitis in patients.
    PLoS One. 2024;19:e0312181.
    >> Share

  118. WEI X, Weng Z, Xu X, Yao J, et al
    Exploration of a miRNA-mRNA network shared between acute pancreatitis and Epstein-Barr virus infection by integrated bioinformatics analysis.
    PLoS One. 2024;19:e0311130.
    >> Share

  119. KOO BW, Oh AY, Na HS, Han J, et al
    Goal-directed fluid therapy on the postoperative complications of laparoscopic hepatobiliary or pancreatic surgery: An interventional comparative study.
    PLoS One. 2024;19:e0315205.
    >> Share


  120. Retraction: Net Expression Inhibits the Growth of Pancreatic Ductal Adenocarcinoma Cell PL45 In Vitro and In Vivo.
    PLoS One. 2024;19:e0315984.
    >> Share

  121. MEHRA T, Lupatsch JE, Koessler T, Dedes K, et al
    Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    PLoS One. 2024;19:e0315976.
    >> Share

  122. BONDE M, Bonde A, Kaafarani H, Millarch A, et al
    Assessing the value of deep neural networks for postoperative complication prediction in pancreaticoduodenectomy patients.
    PLoS One. 2024;19:e0316402.
    >> Share

    January 2023
  123. TIAN W, Zhang L, Liu X, Ma X, et al
    Fluoropyrimidine combination therapy versus fluoropyrimidine monotherapy for gemcitabine-refractory advanced pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2023;18:e0282360.
    >> Share

  124. LARIVUO I, Laukkala H, Nevalainen A, Arponen O, et al
    Psychiatric medications and the risk of autoimmune and immune-mediated inflammatory diseases: A systematic review and meta-analysis of observational studies.
    PLoS One. 2023;18:e0281979.
    >> Share

  125. BASNET S, Ghimire MP, Lamichhane TR, Adhikari R, et al
    Identification of potential human pancreatic alpha-amylase inhibitors from natural products by molecular docking, MM/GBSA calculations, MD simulations, and ADMET analysis.
    PLoS One. 2023;18:e0275765.
    >> Share

  126. WANG L, Luo P, Yang Z, Zhong X, et al
    FOXP1 inhibits pancreatic cancer growth by transcriptionally regulating IRF1 expression.
    PLoS One. 2023;18:e0280794.
    >> Share

  127. POUDEL SK, Padmanabhan R, Dave H, Guinta K, et al
    Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease.
    PLoS One. 2023;18:e0283021.
    >> Share

  128. CHEN Q, Lin J, Chen Z, Che L, et al
    Circular RNA expression alterations and function prediction in OSA-induced pancreatic injury in mice: New insights into pathogenesis.
    PLoS One. 2023;18:e0284459.
    >> Share

  129. HENG X, Chen B, Zhao K, Li J, et al
    Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine Tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
    PLoS One. 2023;18:e0284930.
    >> Share

  130. SHIM JY, Chung JO, Jung D, Kang PS, et al
    Parkin-mediated mitophagy is negatively regulated by FOXO3A, which inhibits Plk3-mediated mitochondrial ROS generation in STZ diabetic stress-treated pancreatic beta cells.
    PLoS One. 2023;18:e0281496.
    >> Share

  131. XIAO X, Wu X, Fu Q, Ren X, et al
    Efficacy and safety of Dachaihu Decoction for acute pancreatitis: Protocol for a systematic review and meta-analysis.
    PLoS One. 2023;18:e0285661.
    >> Share

  132. DIKE CR, Sun QK, Rahib L, Golden M, et al
    Extra-pancreatic manifestations reported in association with pancreatitis; an international survey report.
    PLoS One. 2023;18:e0288337.
    >> Share

  133. AMINI M, Azizmohammad Looha M, Rahimi Pordanjani S, Asadzadeh Aghdaei H, et al
    Global long-term trends and spatial cluster analysis of pancreatic cancer incidence and mortality over a 30-year period using the global burden of disease study 2019 data.
    PLoS One. 2023;18:e0288755.
    >> Share

  134. LING R, Liang J, Mo S, Qi J, et al
    Physical activity, sedentary behavior and pancreatitis risk: Mendelian randomization study.
    PLoS One. 2023;18:e0287810.
    >> Share

  135. SHIMAGAKI T, Sugimachi K, Mano Y, Tomino T, et al
    A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma.
    PLoS One. 2023;18:e0288033.
    >> Share

  136. HEINZMAN C, Hornung L, Lin TK, Lowe CMO, et al
    Total pancreatectomy with islet autotransplantation reduces opioid use and improves nutritional support in children with debilitating pancreatitis.
    PLoS One. 2023;18:e0289620.
    >> Share

  137. KAUR G, Helmer RA, Martinez-Marin D, Sennoune SR, et al
    Helicase-like transcription factor (Hltf)-deletion activates Hmgb1-Rage axis and granzyme A-mediated killing of pancreatic beta cells resulting in neonatal lethality.
    PLoS One. 2023;18:e0286109.
    >> Share

  138. ZHANG Y, Kirk CA, Tolbert MK, Steiner JM, et al
    Impact of fatty acid composition on markers of exocrine pancreatic stimulation in dogs.
    PLoS One. 2023;18:e0290555.
    >> Share

  139. LIU S, Li H, Xue Y, Yang L, et al
    Prognostic value of neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomized controlled trials.
    PLoS One. 2023;18:e0290888.
    >> Share

  140. LAPIN M, Tjensvoll K, Nedrebo K, Taksdal E, et al
    Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.
    PLoS One. 2023;18:e0291623.
    >> Share

  141. JANTHONGKAW A, Klaophimai S, Khampaya T, Yimthiang S, et al
    Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention.
    PLoS One. 2023;18:e0291738.
    >> Share


  142. Ex pression of Concern: Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells.
    PLoS One. 2023;18:e0292422.
    >> Share

  143. AZEVEDO-POULY A, Hale MA, Swift GH, Hoang CQ, et al
    Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation.
    PLoS One. 2023;18:e0291512.
    >> Share

  144. BRAYER KJ, Hanson JA, Cingam S, Martinez C, et al
    The inflammatory response of human pancreatic cancer samples compared to normal controls.
    PLoS One. 2023;18:e0284232.
    >> Share

  145. INGLE K, LaComb JF, Graves LM, Baines AT, et al
    AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
    PLoS One. 2023;18:e0294065.
    >> Share


  146. Retraction: Expression of DNMT1 and DNMT3a Are Regulated by GLI1 in Human Pancreatic Cancer.
    PLoS One. 2023;18:e0294385.
    >> Share

  147. GANDIKOTA HP, S A, M SK
    CT scan pancreatic cancer segmentation and classification using deep learning and the tunicate swarm algorithm.
    PLoS One. 2023;18:e0292785.
    >> Share


  148. Expression of Concern: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
    PLoS One. 2023;18:e0294622.
    >> Share

  149. DAILEY KM, Small JM, Pullan JE, Winfree S, et al
    An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
    PLoS One. 2023;18:e0289183.
    >> Share

  150. KARBHARI A, Mosessian S, Trivedi KH, Valla F Jr, et al
    Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
    PLoS One. 2023;18:e0294564.
    >> Share

  151. KANAPARTHY NS, Loza AJ, Hauser RG
    Crawling toward obsolescence: The extended lifespan of amylase for pancreatitis.
    PLoS One. 2023;18:e0296180.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016